December 5, 2025
FOR IMMEDIATE RELEASE
PILMA Applauds Bipartisan PBM Reform Legislation, Urges Swift Action Before Year’s End
Washington, D.C. – The Pharmaceutical Industry Labor-Management Association (PILMA) today applauded Senate Finance Committee Chairman Mike Crapo (R-Idaho) and Ranking Member Ron Wyden (D-Oregon) for introducing the bipartisan Pharmacy Benefit Manager (PBM) Price Transparency and Accountability Act. This legislation – which in addition to Senators Crapo & Wyden has 19 other co-sponsors in the Senate – represents a comprehensive effort to increase transparency, eliminate harmful middleman practices, and lower prescription drug costs for American patients and families.
“We commend Chairman Crapo and Ranking Member Wyden for their leadership in keeping the momentum on PBM reform alive,” said AJ Stokes, Executive Director of PILMA. “This legislation directly confronts the unchecked power of pharmacy benefit managers whose opaque business practices have driven up costs for working families, strained employer-sponsored and union-managed health plans, and undermined access to affordable medicines. We urge Congress to act swiftly and pass this critical and widely supported legislation, which has previously reached the final stages of the legislative process, before the end of the year.”
Today, over half of prescription drug spending goes not to manufacturers, but to insurers, PBMs, and other middlemen. Harmful practices employed by these middlemen – including spread pricing, withholding rebates meant for patients and plan sponsors, and steering prescriptions to affiliated pharmacies – have created an unsustainable system that places profound strain on working people and their families, including the skilled tradespeople who build America’s pharmaceutical manufacturing infrastructure.
Last year, bipartisan PBM reform came closer than ever before to becoming law. PILMA urges the Senate to move swiftly on this bipartisan legislation and calls on the full Congress to prioritize meaningful PBM reform that will make healthcare more affordable for American workers, lower costs for employers and unions, and save money for taxpayers.
The time is now to ensure meaningful PBM reform finally crosses the finish line.
###